Clinical Trials Directory

Trials / Completed

CompletedNCT02502487

Dorsal Penile Nerve Block for Rigid Cystoscopy in Men

Dorsal Penile Nerve Block for Rigid Cystoscopy in Men: a Single-center, Randomized, Double-blind and Placebo-controlled Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
258 (actual)
Sponsor
West China Hospital · Academic / Other
Sex
Male
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study will determine the effectiveness and safety of dorsal penile nerve block (DPNB) in men undergoing rigid cystoscopy.

Detailed description

Pain is common in men undergoing rigid cystoscopy. Even with application of a lubricant containing 2% lidocaine, about 76% men suffer from mild to severe pain when undergoing rigid cystoscopy, and approximately 27% men could still feel mild to moderate pain 7 days after the procedure. The most painful part of the procedure for men is when the cystoscope passes through the membranous urethra. Song et al did autopsy on males found dorsal nerve of the penis (DNP), the terminal branch of the pudendal nerve, innervates the membranous urethra in 53.3% specimens. In addition, urethral mucosa has branches of DNP innervated. Dorsal penile nerve block (DPNB) is usually used for circumcision in children and it has been shown to provide effective analgesia for penile surgeries. According to the evidence that some DNP branches innervate membranous urethra and urethra mucosa and most pain originates from cystoscope passing through membranous urethra, we speculated that DPNB could overall reduce pain level in men during rigid cystoscopy.

Conditions

Interventions

TypeNameDescription
PROCEDUREDorsal Penile Nerve BlockDorsal penile nerve block with 0.33% ropivacaine using 22-G needle in the sub-pubic space at the base of the penis
DRUGRopivacaine0.33% Ropivacaine administered around dorsal penile nerve using 22-G needle in the sub-pubic space at the base of the penis
DRUGTetracaine1% Tetracaine gel instilled into urethra

Timeline

Start date
2015-06-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2015-07-20
Last updated
2020-03-31
Results posted
2016-07-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02502487. Inclusion in this directory is not an endorsement.